Mixed Adeno-neuroendocrine Carcinoma: An Aggressive Clinical Entity

Annals of Surgical Oncology

Volumn 23, Issue 7, 2016, Pages 2281-2286

  Brathwaite, Shayna ^a   Rock, Jonathan ^a   Yearsley, Martha M ^a   Bekaii Saab, Tanios ^a   Wei, Lai ^a   Frankel, Wendy L ^a   Hays, John ^a   Wu, Christina ^a   Abdel Misih, Sherif ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CHROMOGRANIN; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; SYNAPTOPHYSIN;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; APPENDECTOMY; APPENDIX; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARCINOID; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; EVIDENCE BASED MEDICINE; FEMALE; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MIXED ADENO NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE TUMOR; OVARIECTOMY; OVERALL SURVIVAL; RARE DISEASE; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; ADENOCARCINOMA; APPENDIX TUMOR; CARCINOMA; COLON RESECTION; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APPENDECTOMY; APPENDICEAL NEOPLASMS; CARCINOID TUMOR; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SIGNET RING CELL; COLECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84960466076     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-016-5179-2     Document Type: Article

References (21)

1. Komminoth PA, Capella C, Klimstra DS, Klöppel G, Solcia E, Rindi G. Neuroendocrine neoplasms of the appendix. In: WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010.
2. Rindi G, Bordi C, La Rosa S, et al. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report. Dig Liver Dis. 2011;43 Suppl 4:S356–60.
3. Lewin K. Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol. 1987;11 Suppl 1:71–86.
4. Capella C, La Rosa S, Uccella S, Billo P, Cornaggia M. Mixed endocrine–exocrine tumors of the gastrointestinal tract. Semin Diagn Pathol. 2000;17(2):91–103.
5. Holt N, Gronbaek H. Goblet cell carcinoids of the appendix. Sci World J. 2013;2013:543696–702.
6. Roy P, Chetty R. Goblet cell carcinoid tumors of the appendix: an overview. World J Gastrointest Oncol. 2010;2(6):251–8.
7. La Rosa S, Marando A, Furlan D, Sahnane N, Capella C. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers. Am J Surg Pathol. 2012;36(4):601–11.
8. Power DG, Asmis TR, Tang LH, Brown K, Kemeny NE. High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease. Med Oncol. 2011;28 Suppl 1:S169–74.
9. Shia J, Tang LH, Weiser MR, et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol. 2008;32(5):719–31.
10. La Rosa S, Marando A, Sessa F, Capella C. Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update. Cancers. 2012;4(1):11–30.
11. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3):311–22.
12. Lowe K, Khithani A, Liu E, et al. Ki-67 labeling: a more sensitive indicator of malignant phenotype than mitotic count or tumor size? J Surg Oncol. 2012;106(6):724–7.
13. Hamilton SR, Aaltonen LA, (eds.). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000.
14. Goede AC, Caplin ME, Winslet MC. Carcinoid tumour of the appendix. Br J Surg. 2003;90(11):1317–22.
15. Nussbaum DP, Speicher PJ, Gulack BC, et al. Management of 1- to 2-cm carcinoid tumors of the appendix: using the national cancer data base to address controversies in general surgery. J Am Coll Surg. 2015;220(5):894–903.
16. Mullen JT, Savarese DM. Carcinoid tumors of the appendix: a population-based study. J Surg Oncol. 2011;104(1):41–4.
17. Benedix F, Reimer A, Gastinger I, et al. Primary appendiceal carcinoma—epidemiology, surgery and survival: results of a German multi-center study. Eur J Surg Oncol. 2010;36(8):763–71.
18. Moertel CG, Weiland LH, Nagorney DM, Dockerty MB. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med. 1987;317(27):1699–701.
19. Murray SE, Lloyd RV, Sippel RS, Chen H, Oltmann SC. Postoperative surveillance of small appendiceal carcinoid tumors. Am J Surg. 2014;207(3):342–5; discussion 345.
20. Kulke MH, Shah MH, Benson AB, et al. Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw. 2015;13(1):78–108.
21. McCusker ME, Cote TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973–1998. Cancer. 2002;94(12):3307–12.